Journal of controlled release : official journal of the Controlled Release Society

How mRNA-lipid nanoparticles enter the lymph system and spread through the body after injection into veins or under the skin

Updated

Abstract

After subcutaneous injection, mRNA-LNP components were found at concentrations 10-1000 times higher in thoracic lymph than in plasma.

  • The study quantifies mRNA-LNP transport through lymphatics, which has not been previously measured.
  • SM-102 and MC3 LNP formulations provided the most effective protection of mRNA in plasma after intravenous administration.
  • All formulations showed low bioavailability of mRNA (0.42-0.87% dose) after subcutaneous injection.
  • Ionizable lipids demonstrated greater lymphatic recovery (3.1-4.3% dose) compared to mRNA (0.62-1.4% dose) and PEG lipid (1.9-2.0% dose).
  • Highest protein expression was observed in lymph nodes and nearby tissues, as well as in the liver and spleen 32 hours post-injection.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free